Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Laborit study of sodium oxybate versus lorazepam for catatonia
2021-004049-19Phase 3Active
- Sponsor
- Amsterdam University Medical Center
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in catatonia comparing Sodium oxybate with High-dose lorazepam (2 arms). Primary endpoints: Response on Bush Francis Catatonia Rating Scale and Remission of catatonia after 10 days. Started Sep 2024; status: active.
02
Drugs
sodium oxybatelorazepam
03
Conditions
catatonia
Beyond the preview
Go deeper on 2021-004049-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-004049-19.